Last checked at 14 Oct 2011 16:43
14 October 2011
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Director's Dealing
Port Erin, the newly formed AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, announces that the Company was today notified that Mr Jim Mellon, the Non-executive Chairman of Port Erin, today acquired 240,000 ordinary shares of 0.0001 pence each ("Ordinary Shares") at a price of 8.25 pence per Ordinary Share. Accordingly, Mr Mellon is now interested, in aggregate, in 3,340,000 Ordinary Shares representing approximately 10.12 per cent. of the Company's issued share capital.
Enquiries:
Libertas Capital Corporate Finance Limited
Sandy Jamieson 0207 569 9650
Rivington Street Corporate Finance Limited
Dru Edmonstone/ Jon Levinson 0207 562 3389